The purpose of this study is to find out the optimal dose for Remimazolam Tosilate as an intravenous general anaesthetic drug in operations and to determine its efficacy and safety profile comparing to propofol.
This is an multi-center,double-blinded,parallel and control study using Remimazolam or propofol for anesthesia in operations.Subjects are randomized to different treatment groups (including 3 for Remimazolam Tosilate and 1 for propofol) and anaesthetics are pumped contimuously into bodies.Analgesics and muscle relaxants are permitted during operations.Efficacy,safety and pharmacokinetic/pharmacodynamic profiles of Remimazolam Tosilate are to be evaluated.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
DOUBLE
Enrollment
144
IV pumping for anesthesia
IV bolus for anesthesia
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
successful anaesthesia rate as measured by the proportion of subjects who experienced succesful anesthesia during operations
Time frame: an average of 3 hours (immediately after opaerations)
bispectral index(BIS) during anaesthesia as measured by bispectral index machine
Time frame: every 5 minutes
recovery time as measured by time
Time frame: an average of 3 hours (after cessation of anesthetics pumping)
induction time as measured by time
Time frame: 1-10 minutes (from the begining of anesthetics)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.